CytomX Aktie
0,64
EUR
+0,03
EUR
+4,71
%
0,72
USD
+0,01
USD
+1,42
%
Werbung
CytomX Aktie Analyse
14.05.19 | CytomX Overweight | Cantor Fitzgerald | |
11.03.19 | CytomX overweight | Barclays Capital | |
13.09.18 | CytomX Buy | H.C. Wainwright & Co. | |
08.09.17 | CytomX Outperform | Wedbush Morgan Securities Inc. | |
27.03.17 | CytomX Buy | H.C. Wainwright & Co. | |
02.03.17 | CytomX Buy | Instinet | |
02.11.15 | CytomX Outperform | Oppenheimer & Co. Inc. |
Werbung
Werbung